FDA Investigator Anastasia I Onuorah

Anastasia I Onuorah has inspections in 4 countries as of 17 Nov 2023. Anastasia I Onuorah has collaborated with a combinined 1725 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
17 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, South Africa, Brazil, Chile
Albert A Salvador, Alison N Stieg, Anastasia I Offordile, Anastasia M Shields, Andrea A Branche, Anita R Michael, Atul J Agrawal, Audrey Thereset Uy, Benton M Ketron, Brian S Keefer, Brooke K Higgins, Brooke K Seeman, Byungja E Marciante, Cara M Minelli, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chaltu N Wakijra, Christopher Bastedo, Dawn D Aiello, Debra J Bennett, Dennis L Doupnik, Diane T Bargo, Diane T O'brien, Douglas A Campbell, Emest F Bizjak, Frank W Perrella, Gabrielle J Swain, George Pyramides, Guerlain Ulysse, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, James M Mason, James P Mcevoy, Janet A Rajan, Jeanne J Thai, Jeen S Min, John P Mistler, Johnna L Bleem, Jonathan W Chapman, Joseph L Despins, PhD, Julianne C Mccullough, Katelyn Astaub Zamperini, Kelly N Kerr, Kimberly A Dux, Ko U Min, Kristin M Abaonza, Kristina Conroy, Kristina L Conroy, Krystal O Ogunremi, Kshitij A Patkar, Lance M De Souza, MBA, Lawrence J Stringer, LCDR Margaret E Digennaro, Linda M Hoover, Lisa B Orr, Lucila B Nwatu, Marcelo O Mangalindan, Jr, Marcus A Ray, Massoud Motamed, Matthew R Noonan, Melissa J Garcia, Melissa T Roy, Michael Gurbarg, Michael J Nerz, Michele M Falchek, Michelle Marsh, Mike M Rashti, Nancy M Espinal, Paula J Bretz, Pratik S Upadhyay, DDC, Qin Xu, Rabin N Ghoshal, Rebecca E Dombrowski, Ronald A Stokes, Sam Pepe, Sean R Marcsisin, Sharon K Thoma, PharmD, Sneha Patel, Sneha S Patel, Stephanie Mangigian, MS/OSH, RN, Susan F Laska, MS, Tamika White, Tamil Arasu, PhD, Tania E Vizcaino, Temar Q Williams, Thomas E Friel, Thomas J Arista, Toyin B Oladimeji, Vaishali J Patel, Vlada Matusovsky, William A Warnick, William L Bargo, William V Millar, Yvonne C Mcknight, Yvonne C Wood

Anastasia I Onuorah's Documents

Publish Date Document Type Title
September, 2019 FDA 483 Elizabeth Plimack, MD, MS - Form 483, 2019-09-26
September, 2019 FDA 483 Evan Alley, M.D., Ph.D. - Form 483, 2019-09-05
October, 2023 FDA 483 Kwabena Ntoso M.D - Form 483, 2023-10-11

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more